The Future of Medicare Drug Price Negotiation and Pharmaceutical Innovation
One of the most publicized provisions of the Inflation Reduction Act (IRA) is the section mandating that a small subset of the most expensive pharmaceutical products in the U.S. be subject to Medicare price negotiations. The provision applies only to a minorit... More »